Global Cinnarizine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cinnarizine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cinnarizine is an antihistamine and calcium channel blocker of the diphenylmethylpiperazine group. It is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease.
Cinnarizine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cinnarizine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Antiemetic Agent and Histamine H₁-Receptor Antagonist are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cinnarizine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cinnarizine key manufacturers include Goodwill Pharma, Zambon, Gedeon Richter, Johnson and Johnson, Hasco-Lek, Teva, Sopharma, Aurobindo Pharma and Novartis, etc. Goodwill Pharma, Zambon, Gedeon Richter are top 3 players and held % sales share in total in 2022.
Cinnarizine can be divided into Hospital, Drug Store and On-line,, etc. Hospital is the mainstream product in the market, accounting for % sales share globally in 2022.
Cinnarizine is widely used in various fields, such as Antiemetic Agent, Histamine H₁-Receptor Antagonist and Antivertigo Agent,, etc. Antiemetic Agent provides greatest supports to the Cinnarizine industry development. In 2022, global % sales of Cinnarizine went into Antiemetic Agent filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cinnarizine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Goodwill Pharma
Zambon
Gedeon Richter
Johnson and Johnson
Hasco-Lek
Teva
Sopharma
Aurobindo Pharma
Novartis
Mylan
Eurogenerics
Nidda Healthcare
Apotex
Leti Pharma
Allena Pharmaceuticals
Inga Laboratories
March Pharma
Segment by Type
Hospital
Drug Store
On-line
Antiemetic Agent
Histamine H₁-Receptor Antagonist
Antivertigo Agent
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cinnarizine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cinnarizine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cinnarizine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Cinnarizine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cinnarizine introduction, etc. Cinnarizine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cinnarizine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Cinnarizine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cinnarizine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Antiemetic Agent and Histamine H₁-Receptor Antagonist are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cinnarizine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cinnarizine key manufacturers include Goodwill Pharma, Zambon, Gedeon Richter, Johnson and Johnson, Hasco-Lek, Teva, Sopharma, Aurobindo Pharma and Novartis, etc. Goodwill Pharma, Zambon, Gedeon Richter are top 3 players and held % sales share in total in 2022.
Cinnarizine can be divided into Hospital, Drug Store and On-line,, etc. Hospital is the mainstream product in the market, accounting for % sales share globally in 2022.
Cinnarizine is widely used in various fields, such as Antiemetic Agent, Histamine H₁-Receptor Antagonist and Antivertigo Agent,, etc. Antiemetic Agent provides greatest supports to the Cinnarizine industry development. In 2022, global % sales of Cinnarizine went into Antiemetic Agent filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cinnarizine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Goodwill Pharma
Zambon
Gedeon Richter
Johnson and Johnson
Hasco-Lek
Teva
Sopharma
Aurobindo Pharma
Novartis
Mylan
Eurogenerics
Nidda Healthcare
Apotex
Leti Pharma
Allena Pharmaceuticals
Inga Laboratories
March Pharma
Segment by Type
Hospital
Drug Store
On-line
Segment by Application
Antiemetic Agent
Histamine H₁-Receptor Antagonist
Antivertigo Agent
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cinnarizine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cinnarizine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cinnarizine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Cinnarizine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cinnarizine introduction, etc. Cinnarizine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cinnarizine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.